Crossmark

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2019-000783

Published Online: 2019-10-25

Published Print: 2019-10

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Xu, Liang

Nagata, Naoto

Chen, Guanliang

Nagashimada, Mayumi

Zhuge, Fen

Ni, Yinhua

Sakai, Yuriko

Kaneko, Shuichi

Ota, Tsuguhito https://orcid.org/0000-0003-4238-9061
Funding

Funding for this research was provided by:

Challenging Exploratory Research (15K12698)

Grant-in-Aid for Scientific Research (25282017)